Project Grant F32DK145220
- Project Grant Award Summary Massachusetts General Hospital's Research Management Division received a $842,732 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 8, 2026, with completion targeted for April 30, 2031. The project delivers research services focused on developing and validating pathway-specific polygenic scores (PPGSs) to predict...
- Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Massachusetts General Hospital a $156,510 Project Grant (CFDA 93.847: Diabetes, Digestive, and Kidney Diseases Extramural Research) effective July 1, 2026, through March 31, 2030. Under the direction of Dr. Lee, the award funds development of a precision metabolic risk stratification framework for Type 2 Diabetes (T2D) prevention in patients with Major Depressive Disorder (MDD). The research...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $759,944 to the Regents of the University of Minnesota on March 6, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with an ultimate completion date of February 28, 2031, funds a clinical trial investigating a biologically-based obesity prevention approach in older adolescents and young...
- Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a $330,065 Project Grant to the University of Colorado-Denver on July 10, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a five-year research study examining the dietary reversal of reproductive endocrine dysfunction in women with obesity. The project, which runs through June 30, 2031, will investigate whether a low-fat, eucaloric diet (22%...
- Federal Project Grant Award Summary The University of Pennsylvania received a $2,559,138 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 7, 2025 through August 31, 2029. This research grant supports a comprehensive investigation into adipose tissue metabolic memory and its role in rebound weight gain following successful weight...
- The University of North Carolina at Chapel Hill received a $766,277 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 10, 2025, with completion expected June 30, 2030. The award funds research to optimize dietary adherence in a mobile behavioral weight loss (BWL) intervention for adults with obesity. The project will recruit 580 participants to evaluate a smartphone-based BWL program that...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a $316,936 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Pennington Biomedical Research Center on September 28, 2025. This award funds research leveraging machine learning algorithms and Ecological Momentary Assessment (EMA) data to identify contextual factors predicting children's energy intake. The project will train and test...
- Federal Grant Award Summary Boston University Medical Campus received a $168,252 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through July 31, 2030. The award supports a five-year research and career development initiative conducted by an Assistant Professor of Medicine in the Section of Endocrinology, Diabetes,...
- Grant Award Summary Rockefeller University received a $1.546 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 5, 2025, with completion targeted for June 30, 2030. The award funds investigative research into the transcriptional control mechanisms of adipocyte formation and function through nuclear receptor coactivators. The research...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Alabama at Birmingham $298,000 on August 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a three-year pilot trial evaluating a scalable behavioral intervention for weight loss maintenance following discontinuation of glucagon-like peptide-1 (GLP-1) receptor agonists and anti-obesity medications. The...
EXAMINATION OF METABOLIC CHARACTERISTICS IN THE PREDISPOSITION FOR WEIGHT GAIN - PROJECT SUMMARY OBESITY, OFTEN CHARACTERIZED BY WEIGHT GAIN FROM OVER-NUTRITION, IS ONE OF THE GREATEST RISK FACTORS OF PREVENTABLE MORBIDITY AND MORTALITY WORLDWIDE. OBESITY IS EVIDENT IN >40% OF US ADULTS, WITH PREVALENCE PROJECTED TO REACH 50% BY 2030. DRIVEN BY A MULTITUDE OF BOTH MODIFIABLE AND NON-MODIFIABLE FACTORS, THERE IS OBSERVED VARIATION IN THE MAGNITUDE OF WEIGHT GAINED IN BOTH CONTROLLED AND FREE-LIVING SETTINGS. THIS OBSERVATION WAS REPEATED IN THE LARGEST CONTROLLED OVERFEEDING TRIAL TO DATE, EAT (NCT01672632; N=35), AND IN THE 8-YEAR WEIGHT MAINTENANCE DATA FROM THE LOOK AHEAD TRIAL (NCT00017953; N=4,127). INDIVIDUAL FACTORS INCLUDING GENETICS, INSULIN SENSITIVITY, AND SUBSTRATE UTILIZATION HAVE BEEN SHOWN TO PLAY A SIGNIFICANT ROLE IN THE PREDISPOSITION FOR WEIGHT GAIN. HOWEVER, THE COMBINED ROLES OF FACTORS DRIVING VARIABILITY IN WEIGHT GAIN REMAIN POORLY UNDERSTOOD. THE OVERARCHING GOAL OF THIS INNOVATIVE F32 FELLOWSHIP IS TO IDENTIFY METABOLIC FACTORS PREDICTIVE OF WEIGHT GAIN AHEAD). IN AIM 1, WE WILL LEVERAGE STATE-OF-THE-ART METABOLIC PHENOTYPING METHODOLOGY TO IDENTIFY METABOLIC CHARACTERISTICS THAT EXPLAIN VARIATION IN TWO DIFFERING WEIGHT GAIN PARADIGMS: CONTROLLED OVERFEEDING (EAT) AND PROSPECTIVE WEIGHT REGAIN (LOOK AHEAD-ANCILLARY STUDY N=59). IN SUB-AIM 1, WE WILL USE UNTARGETED METABOLOMICS TO EXPLAIN ADDITIONAL VARIABILITY IN WEIGHT GAIN IN RESPONSE TO CONTROLLED OVERFEEDING . AIM 2 WILL THEN UTILIZE MACHINE LEARNING APPROACHES TO CONFIRM PREDICTIVE FACTORS OF WEIGHT REGAIN UTILIZING ROUTINE CLINICAL MEASURES (LOOK AHEAD). ADDRESSING THESE AIMS WILL PROVIDE NEW INFORMATION REGARDING THE "GROUND TRUTH" OF METABOLIC PREDISPOSITION TOWARDS WEIGHT GAIN AND GENERATE EVIDENCE FOR CHARACTERIZING A PHENOTYPE OF LIKELY WEIGHT GAIN THAT WILL HAVE FUTURE IMPLICATIONS IN GUIDING PERSONALIZED APPROACHES TO HEALTHY WEIGHT MANAGEMENT. THIS SECONDARY ANALYSIS WILL BE SUPPORTED BY MENTORED AND HANDS-ON TRAINING IN 1) METABOLIC PHENOTYPING METHODS, 2) ADVANCED BIOSTATISTICS INCLUDING MACHINE LEARNING, AND 3) PROFESSIONAL AND CAREER DEVELOPMENT. THE APPLICANT WILL WORK CLOSELY WITH HER PRIMARY SPONSOR, DR. URSULA WHITE (AN EXPERT IN METABOLIC PHENOTYPING), AND HER CO-SPONSORS DR. LEANNE REDMAN (EXPERT IN ENERGY METABOLISM AND PRECISION NUTRITION), DR. SHENGPING YANG (EXPERT IN BIOSTATISTICS AND MACHINE LEARNING), AND DR. CHRISTOPHER NEWGARD (EXPERT IN METABOLOMICS ANALYSES) AND CONSULT DR. DIANA THOMAS (EXPERT IN MACHINE LEARNING AND PREDICTIVE MODELING). THIS COMPREHENSIVE TRAINING PLAN, IN COMBINATION WITH THE RESOURCES AVAILABLE THROUGH PENNINGTON BIOMEDICAL RESEARCH CENTER, PROVIDES IDEAL CONDITIONS TO FOSTER THE APPLICANT'S FUTURE INDEPENDENT RESEARCH CAREER. THIS IS AN EXCEPTIONAL MENTORING AND TRAINING OPPORTUNITY TO BUILD NEW EXPERTISE IN METABOLIC PHENOTYPING, ADDING TO THE APPLICANT'S EXISTING EXPERTISE AS A REGISTERED DIETICIAN AND NUTRITIONAL SCIENTISTS LEADING TO THE APPLICANT'S ABILITY TO CONTRIBUTE TO HIGH IMPACT CROSS-DISCIPLINARY APPROACHES TO ADDRESS QUESTIONS REGARDING TAILORING DIETARY APPROACHES FOR HEALTHY WEIGHT MANAGEMENT AND IMPROVED CARDIOMETABOLIC HEALTH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $79.6k | 3/19/26 |